Vaccinating against covid-19 in people who report allergies.

Glover, Rebecca E; Urquhart, Robert; Lukawska, Joanna; Blumenthal, Kimberly G

Glover, Rebecca E; Urquhart, Robert; Lukawska, Joanna; Blumenthal, Kimberly G.

Glover RE; AMR Centre, London School of Hygiene and Tropical Medicine, London, UK rebecca.glover@lshtm.ac.uk.
Urquhart R; University College London Hospitals NHS Trust, London, UK.
Lukawska J; Department of Specialist Allergy and Clinical Immunology, University College London Hospitals, London, UK.
Blumenthal KG; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

BMJ ; 372: n120, 2021 01 18.

Article in English | MEDLINE | ID: covidwho-1066860

Subject(s)

Anaphylaxis/epidemiology; COVID-19 Vaccines/therapeutic use; COVID-19/prevention & control; Contraindications, Drug; Anaphylaxis/chemically induced; BNT162 Vaccine; ChAdOx1 nCoV-19; Drug Hypersensitivity/epidemiology; Drug Hypersensitivity/etiology; Humans; Patient Education as Topic; Patient Selection; Polyethylene Glycols/adverse effects; SARS-CoV-2; United Kingdom

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Contraindications, Drug / COVID-19 Vaccines / COVID-19 / Anaphylaxis Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: BMJ Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Bmj.n120

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google